BZAM Ltd. BZAM BZAMF entered into an engagement letter with Clarus Securities under which Clarus will conduct a private placement of at least 15.38 million units at an issue price of CA$0.13 per unit ($0.095) for aggregate gross proceeds of approximately CA$2 million.
“We are incredibly grateful for the support of our chairman throughout the post-merger integration process,” Matt Milich, BZAM CEO stated. “Now that we have effectively completed our post-merger plan, we look forward to the next chapter as we target positive free cash flow in the first quarter of 2024.”
Each unit will consist of one common share and one share purchase warrant, with each warrant entitling the holder thereof to acquire one share at an exercise price of CA$0.18 per warrant share for a period of three years from the closing date.
Further to the engagement letter, the agent may offer up to a maximum of 21.15 million units for aggregate gross proceeds of approximately CA$2.75 million and the company has granted the agent an option exercisable in whole or in part, to purchase up to an additional 3.17 million units for a period of 30 days from and including the closing date to cover over-allotments, if any, and for market stabilization purposes. If the over-allotment option is exercised in full, the aggregate gross proceeds of the offering will be around CA$3.16 million.
BZAM plans to use the proceeds of the offering for general corporate expenses and working capital purposes.
The offering is expected to close on or about October 12, 2023, or such other date as may be agreed upon by the company and the agent and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange.
Price Action
BZAM shares traded 18.08% lower at $0.11 per share at the time of publishing Tuesday morning.
Related Links:
Layoffs & Facility Sales Save Millions For This Cannabis Producer As It Eyes European Market
BZAM Q2 Revenue Grows 66% YoY, What About Profit?
Photo: Courtesy of Ryan Lange via Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
